BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders Life Science Investing
Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board Pharmaceutical Investing
Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday, February 1, 2022 Pharmaceutical Investing
Sirona Biochem Renews Agreement with CURE Intelligence for Marketing and Communications Support Life Science Investing
U.S. FDA Approves RINVOQ® to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis Pharmaceutical Investing
Naturally Splendid Closes Second Tranche of $1,120,456 for a Total Raise of $3,270,971 Life Science Investing
Komo Plant Based Foods to Launch in Whole Foods Market Retail Locations in Western Canada Life Science Investing
